Rare genetic mutations have led scientists to surprising blood pressure discoveries
Time of Update: 2022-10-20
” Image credit: Dr. Brandon Michael Blobner The kidneys are often the unsung heroes of maintaining healthy blood pressure, filtering 180 liters of fluid and a pound of salt a day to maintain blood pressure levels.
Researchers at the Mayo Clinic have identified resistance factors for advanced prostate cancer
Time of Update: 2022-10-01
In a new study published in Molecular Cancer Research, Mayo Clinic researchers found that Abblonolone acetate/prednisone is the standard treatment for progressive, incurable, and castration-resistant prostate cancer, resulting in key genomic changes in its response.
The pharmaceutical company's current personnel "earthquake": the president resigned, and the CEO of the subsidiary changed
Time of Update: 2022-09-21
Previously, the combination therapy of "amphavir monoclonal antibody" and "romizumab" of Tengsheng Bo Pharmaceuticals has received high attention, and since the drug was approved for listing at the end of last year, the company announced the commercialization of the product in China in July 2022, and the price is expected to be within 10,000 yuan.
An international multi-center Phase II/III clinical study of zolitinib in the treatment of NSCLC with CNS metastasis completed the final visit of the last subject
Time of Update: 2022-09-10
Zolitinib is a next-generation EGFR-TKI drug designed for the treatment of advanced non-small cell lung cancer with CNS metastases, with the ability to completely penetrate the blood-brain barrier Top
Announcement of the Henan Provincial Market Supervision and Administration Bureau on 37 batches of unqualified food (No. 21, 2022
Time of Update: 2022-08-19
Recently, the Henan Provincial Market Supervision and Administration Bureau organized sampling inspections of biscuits, catering food, egg products, condiments, soy products, instant food, bee products, cakes, alcohol, processed grain products, meat products, dairy products, edible agricultural products, edible Oil, grease and its products, 1837 batches of food samples of 15 categories of beverages, 1800 batches of qualified samples for sampling inspection items, and 37 batches of unqualified samples .
In 2022, the patents of these 29 original research drugs will expire
Time of Update: 2022-06-16
With the normalized implementation of centralized procurement in recent years, generic drug companies are facing huge competition and transformation pressure . How to comply with policy trends, how
Paxlovid fails in post-exposure prophylactic use study
Time of Update: 2022-05-26
Recently, Pfizer reported top-line results from the Phase II/III EPIC-PEP study, showing that Paxlovid failed to significantly reduce the risk of contracting COVID-19 .
statisticsThe oral antiviral drug is currently approved for conditional or emergency use in more than 60 countries, including the United States, to treat high-risk COVID-19 patients .
The "first brother" of the pharmaceutical stock lost its market value of 400 billion, who is the most resistant to the TOP20
Time of Update: 2022-04-24
As of now, among the TOP20 pharmaceutical stocks, 9 companies, including Mindray Medical, WuXi AppTec, Hengrui Medicine, and Pien Tze Huang, have a market value of more than 100 billion yuan; only 4 have positive growth in terms of price changes.
The net profit of Rejing, Zhijiang, Kaili and Jiu'an increased by more than 3 times
Time of Update: 2022-03-07
In addition to the significant increase in foreign trade orders and related income of overseas new crown detection reagents due to the impact of the Delta and Omicron epidemics, some medical device companies have taken new steps in high-quality innovation and development, with considerable benefits .
The 2021 national talks are on the spot: a variety of PD-(L)1 confrontation BMSs are absent; CAR-T has not appeared in ADC, small molecule inhibitors are hotly talked
Time of Update: 2021-12-08
Although the final results of the negotiations have not yet been released, the share prices of domestic PD-1 companies Hengrui, Junshi, Cinda, and BeiGene have soared after the medical insurance negotiations in the morning.
Announcement of the Shandong Provincial Market Supervision Administration on 26 batches of unqualified foods No. 65, 2021 (Total No. 337
Time of Update: 2021-12-03
(D) Lingxian sun supermarket sales of peppers, emamectin benzoate does not meet national standards for food safety regulations, quality inspection agency in Shandong, China Inspection Company Limited detection test .
University of Macau proposes new strategy for precision treatment of breast cancer
Time of Update: 2021-12-02
Photo courtesy of the University of Macau The research team led by Professor Deng Chuxia of the Faculty of Health Sciences of the University of Macau and its collaborators use research methods such as tumor organoid culture and in vitro drug sensitivity screening to provide individualized treatment for different breast cancer patients, especially advanced breast cancer patients.
Vertex's first patient's stem cell-derived therapy results in the treatment of type 1 diabetes on the 90th day
Time of Update: 2021-11-04
"Xander Harvard University professor, researcher Doug Melton Howard Institute The doctor said: "More than ten years ago, our laboratory had a vision to develop islet cell replacement therapy to provide functional treatment for people with T1D .
Application of Nature Machine Learning in Prostate Cancer Disease Prediction
Time of Update: 2021-10-22
Specifically, based on the hierarchical concept of biological neural networks, the author integrated 3007 sets of biological network maps, constructed a deep learning prediction model, input the genome of prostate cancer patients, and through calculations, the first layer can output a series of gene clusters.
When the centralized procurement of biopharmaceuticals is on the agenda, how should pharmaceutical companies deploy
Time of Update: 2021-09-12
For example, on July 15-16, 2020, relevant departments of the National Medical Security Administration held a symposium to listen to expert opinions and suggestions on the centralized procurement of biological products (including insulin) and Chinese patent medicines, study and improve procurement policies in related fields, and promote procurement methods Reform .